Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2008 (2008), Article ID 769795, 8 pages
http://dx.doi.org/10.1155/2008/769795
Research Article

M-CSF and GM-CSF Regulation of STAT5 Activation and DNA Binding in Myeloid Cell Differentiation is Disrupted in Nonobese Diabetic Mice

1College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610, USA
2Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, P. O. BOX 100275, 1600 SW Archer Road, Gainesville, FL 32610, USA
3Burnham Institute for Medical Research-Lake Nona, SLSL Buliding M6-1025, Rm 102-9, Kennedy Space Center, Lake Nona, FL 32899, USA

Received 4 May 2008; Revised 13 August 2008; Accepted 23 October 2008

Academic Editor: Chaim Putterman

Copyright © 2008 B. Rumore-Maton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Teglund, C. McKay, E. Schuetz et al., “STAT5A and STAT5B proteins have essential and nonessential, or redundant, roles in cytokine responses,” Cell, vol. 93, no. 5, pp. 841–850, 1998. View at Publisher · View at Google Scholar
  2. J. A. Hamilton, “GM-CSF in inflammation and autoimmunity,” Trends in Immunology, vol. 23, no. 8, pp. 403–408, 2002. View at Publisher · View at Google Scholar
  3. S. I. Hashimoto, I. Komuro, M. Yamada, and K. S. Akagawa, “IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages,” Journal of Immunology, vol. 167, no. 7, pp. 3619–3625, 2001. View at Google Scholar
  4. F. Piazza, J. Valens, E. Lagasse, and C. Schindler, “Myeloid differentiation of FdCP1 cells is dependent on STAT5 processing,” Blood, vol. 96, no. 4, pp. 1358–1365, 2000. View at Google Scholar
  5. K. Yamaoka, T. Otsuka, H. Niiro et al., “Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes,” Journal of Immunology, vol. 160, no. 2, pp. 838–845, 1998. View at Google Scholar
  6. H. Nakajima, P. K. Brindle, M. Handa, and J. N. Ihle, “Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription,” The EMBO Journal, vol. 20, no. 23, pp. 6836–6844, 2001. View at Publisher · View at Google Scholar
  7. M. Azam, H. Erdjument-Bromage, B. L. Kreider et al., “Interleukin-3 signals through multiple isoforms of STAT5,” The EMBO Journal, vol. 14, no. 7, pp. 1402–1411, 1995. View at Google Scholar
  8. R. L. Ilaria Jr., R. G. Hawley, and R. A. Van Etten, “Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation,” Blood, vol. 93, no. 12, pp. 4154–4166, 1999. View at Google Scholar
  9. R. L. Rosen, K. D. Winestock, G. Chen, X. Liu, L. Hennighausen, and D. S. Finbloom, “Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes,” Blood, vol. 88, no. 4, pp. 1206–1214, 1996. View at Google Scholar
  10. D. V. Serreze, H. R. Gaskins, and E. H. Leiter, “Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice,” Journal of Immunology, vol. 150, no. 6, pp. 2534–2543, 1993. View at Google Scholar
  11. J. Morin, A. Chimènes, C. Boitard, R. Berthier, and S. Boudaly, “Granulocyte-dendritic cell unbalance in the non-obese diabetic mice,” Cellular Immunology, vol. 223, no. 1, pp. 13–25, 2003. View at Publisher · View at Google Scholar
  12. M. J. Clare-Salzler, “The immunopathogenic roles of antigen presenting cells in the NOD mouse,” in NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and other Diseases, E. H. Leiter and M. A. Atkinson, Eds., pp. 101–120, Landes Bioscience, Austin, Tex, USA, 1998. View at Google Scholar
  13. M. Feili-Hariri and P. A. Morel, “Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains,” Clinical Immunology, vol. 98, no. 1, pp. 133–142, 2001. View at Publisher · View at Google Scholar
  14. S. A. Litherland, T. X. Xie, A. Hutson et al., “Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus,” The Journal of Clinical Investigation, vol. 104, no. 4, pp. 515–523, 1999. View at Publisher · View at Google Scholar
  15. S. A. Litherland, J.-X. She, D. Schatz et al., “Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset,” Pediatric Diabetes, vol. 4, no. 1, pp. 10–18, 2003. View at Publisher · View at Google Scholar
  16. A. Abou-Raya and S. Abou-Raya, “Inflammation: a pivotal link between autoimmune diseases and atherosclerosis,” Autoimmunity Reviews, vol. 5, no. 5, pp. 331–337, 2006. View at Publisher · View at Google Scholar
  17. G. Bouma, J. M. C. Coppens, W.-K. Lam-Tse et al., “An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes,” Clinical and Experimental Immunology, vol. 141, no. 3, pp. 509–517, 2005. View at Publisher · View at Google Scholar
  18. S. A. Litherland, T. X. Xie, K. M. Grebe, Y. Li, L. L. Moldawer, and M. J. Clare-Salzler, “IL10 resistant PGS2 expression in at-risk/type 1 diabetic human monocytes,” Journal of Autoimmunity, vol. 22, no. 3, pp. 227–233, 2004. View at Publisher · View at Google Scholar
  19. S. A. Litherland, T. X. Xie, K. M. Grebe et al., “Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages,” Journal of Autoimmunity, vol. 24, no. 4, pp. 297–310, 2005. View at Publisher · View at Google Scholar
  20. S. A. Litherland, K. M. Grebe, N. S. Belkin et al., “Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction,” Journal of Immunology, vol. 175, no. 7, pp. 4561–4565, 2005. View at Google Scholar
  21. A. F. Valledor, F. E. Borràs, M. Cullell-Young, and A. Celada, “Transcription factors that regulate monocyte/macrophage differentiation,” Journal of Leukocyte Biology, vol. 63, no. 4, pp. 405–417, 1998. View at Google Scholar
  22. K. S. Akagawa, “Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages,” International Journal of Hematology, vol. 76, no. 1, pp. 27–34, 2002. View at Publisher · View at Google Scholar
  23. X. Chen, J. Wang, D. Woltring, S. Gerondakis, and M. F. Shannon, “Histone dynamics on the interleukin-2 gene in response to T-cell activation,” Molecular and Cellular Biology, vol. 25, no. 8, pp. 3209–3219, 2005. View at Publisher · View at Google Scholar
  24. K. Ito, P. J. Barnes, and I. M. Adcock, “Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12,” Molecular and Cellular Biology, vol. 20, no. 18, pp. 6891–6903, 2000. View at Publisher · View at Google Scholar
  25. S. T. Smale, “The establishment and maintenance of lymphocyte identity through gene silencing,” Nature Immunology, vol. 4, no. 7, pp. 607–615, 2003. View at Publisher · View at Google Scholar
  26. F. Seydel, E. Garrigan, B. Stutevoss et al., “GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells,” Journal of Autoimmunity, vol. 31, pp. 377–384, 2008. View at Publisher · View at Google Scholar